These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 670126)

  • 1. In vitro susceptibility studies with piromidic acid.
    Garcia Rodgriguez JA; Gomez Garcia AC; Saenz Gonzalez MC
    J Antimicrob Chemother; 1978 May; 4(3):289-91. PubMed ID: 670126
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of beta-hydroxy-piromidic acid against Staphylococcus aureus and enterobacteriaceae.
    García-Rodriguez JA; Gómez-García AC; Rodrigo N; Sáenz MC
    J Antimicrob Chemother; 1982 Jun; 9(6):493-5. PubMed ID: 7107550
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative in vitro studies of nalidixic acid, oxolinic acid, and a new analog with thieno (2,3-b) pyridine structure.
    Gilis PM; Haemers A; Pattyn SR
    Antimicrob Agents Chemother; 1978 Mar; 13(3):533-5. PubMed ID: 263890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of six quinolone antibacterials (author's transl)].
    Soussy CJ; Thibault M; Kitzis MD; Acar JF; Duval J; Chabbert YA
    Ann Microbiol (Paris); 1977 Jul; 128B(1):19-33. PubMed ID: 907268
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of the antibacterial effects of ofloxacin, oxolinic acid and nalidixic acid].
    Langsádl L; Menkyna R; Golier J; Silan L
    Cesk Epidemiol Mikrobiol Imunol; 1988 Sep; 37(5):297-308. PubMed ID: 3197127
    [No Abstract]   [Full Text] [Related]  

  • 6. [A comparison of the effects of three urinary infection chemotherapeutics - nalidixic, oxolinic, and pipemidic acids (author's transl)].
    Langsádl L; Polívková-Konícková L; Roubínek F
    Cas Lek Cesk; 1979 May; 118(19):588-92. PubMed ID: 498218
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of 2 quinoline derivatives, oxolinic and piromidic acid].
    Grima P
    Boll Chim Farm; 1979 Jul; 118(7):363-7. PubMed ID: 526354
    [No Abstract]   [Full Text] [Related]  

  • 9. Monocyclic and tricyclic analogs of quinolones: mechanism of action.
    Georgopapadakou NH; Dix BA; Angehrn P; Wick A; Olson GL
    Antimicrob Agents Chemother; 1987 Apr; 31(4):614-6. PubMed ID: 3037999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of miloxacin.
    Izawa A; Kisaki Y; Irie K; Eda Y; Nakagome T; Komatsu T
    Antimicrob Agents Chemother; 1980 Jul; 18(1):37-40. PubMed ID: 7416749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity of clinical isolates of several enterobacteriaceae, pseudomonas aeruginosa, staphylococcus aureus and streptococcus faecalis to antibiotics. Results of a supraregional collaborative study of the "work-group on resistance" of the Paul Ehrlich Society for Chemotherapy (author's transl)].
    Paul-Ehrlich-Gesellschaft
    Infection; 1978; 6(1):35-44. PubMed ID: 415984
    [No Abstract]   [Full Text] [Related]  

  • 12. [Minimal inhibitory concentration in hospital bacteria].
    Marcenac FM; Fernández AJ; Rebollo MN; Helou HT; Civalero TR; Herran IL; Magri MA
    Rev Asoc Argent Microbiol; 1974; 6(2):44-61. PubMed ID: 4467221
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative studies of the effect of oxolinic and nalidixic acids on urinary flora].
    Balog F; Këvesh SH; Kochish B
    Urol Nefrol (Mosk); 1974; (6):25-8. PubMed ID: 4446181
    [No Abstract]   [Full Text] [Related]  

  • 14. [Present frequency of the different Serratia species isolated in Grenoble University Hospital Center (author's transl)].
    Croize J; Le Noc P
    Pathol Biol (Paris); 1977 Nov; 25(9):617-21. PubMed ID: 341050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility comparisons and recommendations for oxolinic acid.
    Klein D; Matsen JM
    Antimicrob Agents Chemother; 1976 Apr; 9(4):649-54. PubMed ID: 1267439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination effects of chemotherapeutic agents. I. Antagonistic effects of 1,10-phenantbroline with nalidixic acid and piromidic acid on the growth of Escherichia coli.
    Yamabe S; Shimizu M
    J Antimicrob Chemother; 1977 Jan; 3(1):101-4. PubMed ID: 321411
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Oxolinic acid in urinary infections.
    Grüneberg RN
    Lancet; 1974 Nov; 2(7888):1088-9. PubMed ID: 4138360
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on cinoxacin. 1. In vitro activity of cinoxacin, as compared to nalidixic acid, against urinary tract pathogens.
    Mårdh PA; Collen S; Andersson KE
    J Antimicrob Chemother; 1977 Sep; 3(5):411-6. PubMed ID: 903323
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of oxolinic acid and nalidixic acid against common urinary pathogens: a comparative study.
    de Rautlin de la Roy Y; Toma V; Bobin B
    Curr Med Res Opin; 1978; 5(9):743-8. PubMed ID: 738079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro studies of cinoxacin, nalidixic acid, and oxolinic acid.
    Gordon RC; Stevens LI; Edmiston CE; Mohan K
    Antimicrob Agents Chemother; 1976 Dec; 10(6):918-20. PubMed ID: 12717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.